Organization · Venture Capital
MVM Partners
MVM Partners is a healthcare venture capital firm founded in 1997, with offices in Boston, London, and the San Francisco Bay Area. The firm invests in high-growth healthcare businesses across various sectors, focusing on companies with differentiated technologies that address significant unmet medical needs.
Overview
What MVM Partners does
What MVM Partners is
MVM Partners is a healthcare venture capital firm founded in 1997, with offices in Boston, London, and the San Francisco Bay Area. The firm invests in high-growth healthcare businesses across various sectors, focusing on companies with differentiated technologies that address significant unmet medical needs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1997
- Approximate age
- About 29 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find MVM Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
MVM Partners as a funder
Investment thesis
MVM invests in high-growth healthcare businesses addressing significant unmet needs in large markets. The firm seeks companies with differentiated technology and durable protection against competition, working closely with management teams to drive growth and establish new standards of care.
Focus narrative
MVM Partners invests broadly across the healthcare and life sciences sectors, including medical devices, pharmaceuticals, diagnostics, digital health, health IT, life science tools, contract research, and contract manufacturing. The firm targets companies that address significant unmet needs in large markets, typically making aggregate investments of $20 to $100 million in each portfolio company.
Value beyond capital
MVM Partners adds value to its portfolio companies by collaborating closely with management teams to drive growth, make strategic acquisitions, and establish new standards of care. The firm leverages its extensive industry expertise and network to support innovative healthcare solutions.
Terms and economics
- Typical check
- $20,000,000–$100,000,000
- Sweet spot
- $40,000,000
Focus and fit
- Stages
- Series A · Series B · Growth Equity
- Sectors
- Healthcare · Biotech · Medical Devices · Diagnostics · Digital Health
- Regions
- Global · North America · Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Nalu Medical, Paratek Pharmaceuticals, and Zimmer Biomet
Portfolio context
MVM Partners maintains a concentrated portfolio of innovative healthcare companies. Notable former portfolio companies include: Nalu Medical: Acquired by Boston Scientific; Proverum: Received FDA approval for the ProVee System; GT Medical Technologies: Demonstrated significant reductions in brain tumor recurrence risk; Paratek Pharmaceuticals: Completed acquisition of Optinose; Zimmer Biomet: Acquired Paragon 28.
Common questions
What to know about MVM Partners
Upseed classifies MVM Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.